Literature DB >> 10827139

Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure.

J M Hare1, R A Lofthouse, G J Juang, L Colman, K M Ricker, B Kim, H Senzaki, S Cao, R S Tunin, D A Kass.   

Abstract

Myocardial NO signaling appears elevated in heart failure (HF). Whether this results from increased NO production, induction of the high-output NO synthase (NOS)2 isoform, or changes in NOS regulatory pathways (such as caveolae) remains controversial. We tested the hypothesis that increased abundance of caveolin-3 and/or sarcolemmal caveolae contribute to increased NO signaling in pacing-induced HF. Abundance of caveolin-3 (0.59+/-0.08 versus 0.29+/-0.08 arbitrary units, P = 0.01) but not caveolin-1 was increased in HF compared with control conditions, assessed by Western blot. Additionally, transmission electron microscopy revealed increased caveolae (2. 7+/-0.4 versus 1.3+/-0.3 per micrometer myocyte membrane, P<0.005). The association between caveolin-3 and NOS3 at the sarcolemma and T tubules was unchanged in HF compared with control myocytes. The impact of NOS inhibition with L-N(G)-methylarginine hydrochloride (L-NMMA) on beta-adrenergic inotropy was assessed in conscious dogs before and after HF. In control dogs, dobutamine (5 microg. kg(-1) x min(-1)) increased +dP/dt by 36+/-7%, and this was augmented to 66+/-24% by 20 mg/kg L-NMMA (P = 0.04 versus without L-NMMA, n = 8) but not affected by 10 mg/kg L-NMMA (34+/-10%, P = NS; n = 8). In HF, dobutamine +dP/dt response was depressed (P<0.001 versus control), and increased concentrations were required to match control inotropic responses (10 to 15 microg. kg(-1) x min(-1), 48+/-7%). L-NMMA enhanced +dP/dt responses similarly at 10 mg/kg (61+/-17%, P = 0.02; n = 4) and 20 mg/kg (54+/-7%, P = 0.04; n = 7). Caveolin-3 abundance positively correlated with L-NMMA augmentation of dobutamine inotropic responses in HF (r = 0.9, P = 0.03; n = 4). Thus, in canine pacing-induced HF, expression of caveolin-3 and of sarcolemmal caveolae is increased. This increase is associated with augmented agonist-stimulated NO signaling, likely via a compartmentation effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10827139     DOI: 10.1161/01.res.86.10.1085

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  29 in total

1.  beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility.

Authors:  P Varghese; R W Harrison; R A Lofthouse; D Georgakopoulos; D E Berkowitz; J M Hare
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling.

Authors:  Nazareno Paolocci; Tatsuo Katori; Hunter C Champion; Marcus E St John; Katrina M Miranda; Jon M Fukuto; David A Wink; David A Kass
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-18       Impact factor: 11.205

Review 3.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

Review 4.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 5.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

Review 6.  Specificity in S-nitrosylation: a short-range mechanism for NO signaling?

Authors:  Antonio Martínez-Ruiz; Inês M Araújo; Alicia Izquierdo-Álvarez; Pablo Hernansanz-Agustín; Santiago Lamas; Juan M Serrador
Journal:  Antioxid Redox Signal       Date:  2013-01-04       Impact factor: 8.401

7.  Caveolin-3 associates with and affects the function of hyperpolarization-activated cyclic nucleotide-gated channel 4.

Authors:  Bin Ye; Ravi C Balijepalli; Jason D Foell; Stacie Kroboth; Qi Ye; Yu-Hong Luo; Nian-Qing Shi
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

8.  Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism.

Authors:  Jochen Steppan; Sungwoo Ryoo; Karl H Schuleri; Chris Gregg; Rani K Hasan; A Ron White; Lukasz J Bugaj; Mehnaz Khan; Lakshmi Santhanam; Daniel Nyhan; Artin A Shoukas; Joshua M Hare; Dan E Berkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

Review 9.  Caveolae, ion channels and cardiac arrhythmias.

Authors:  Ravi C Balijepalli; Timothy J Kamp
Journal:  Prog Biophys Mol Biol       Date:  2009-01-30       Impact factor: 3.667

Review 10.  Alterations in ryanodine receptors and related proteins in heart failure.

Authors:  Sameer Ather; Jonathan L Respress; Na Li; Xander H T Wehrens
Journal:  Biochim Biophys Acta       Date:  2013-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.